It’s simple. We tried other IR firms and came back to CHF. They’re the best.

We have been working with CHF for almost two years now and have been very happy with the representation we have received from the team. During that time, we have seen important increases in investor recognition of Imperial as a significant critical materials player, particularly scandium, especially as it relates to digital media. Where our social media presence had been lacking prior to engaging CHF, we now have an ever-increasing following on Facebook, Twitter and LinkedIn.

We have had the pleasure of having Cathy and her team represent us for many years, and we are impressed with the courtesy, professionalism and effort everyone puts forth on our behalf. We turned to her group for assistance in several fund raisings and we were able to raise almost twice what we were looking for, largely due to the group’s work ethic and network. 

The CHF team have been a fantastic partner for Avicanna during the past year and have been a great fit for our complex and fast-growing company, where a sophisticated understanding of our business and the market, in addition to their bespoke approach, were all critical in the development and implementation of our investor relations strategy. One of the pioneers of the emerging cannabis sector, and one that has taken a bio-pharmaceutical approach, we often face significant levels of stigma and scrutiny that I believe the CHF team have helped us navigate with their approach.

We have worked continuously with CHF since we went public in 2011. They do everything for us from editing/writing releases, newsletters and presentations to finding investors for private placements. Their outreach, digital and social media programs and handling calls and emails from shareholders frees me up to focus on building our business.